ERIKA BOLTON: Open Payments
NPI 1528453198 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,686 in 91 payments from 24 companies in 2025. Trend: 2023 $1,901 · 2024 $1,858 · 2025 $1,686
Food & beverage: $1,686
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $214 |
| PFIZER INC. | 11 | $202 |
| Axsome Therapeutics, Inc. | 6 | $153 |
| Lilly USA, LLC | 8 | $126 |
| Sumitomo Pharma America, Inc. | 7 | $113 |
| Novo Nordisk Inc | 5 | $111 |
| Astellas Pharma US Inc | 5 | $97 |
| Abbott Laboratories | 5 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
Products named: UBRELVY, MOUNJARO, GEMTESA, ELIQUIS, Veozah, FREESTYLE LIBRE 3, Kerendia, Symbravo.
Industry payments across AL — which companies pay providers there.
